CENTER OF MOLECULAR IMMUNOLOGY

Trials shown by sponsor

Public title	Date of Registration	State
Itolizumab-Plasmapheresis in patients with COVID-19	30/06/2021	Registered
VSSPs in renal carcinoma.	21/06/2023	Registered
Nimotuzumab in COVID-19	21/05/2021	Registered
CIMAvax-EGF/Lung cancer/Biomarkers/Prospective CT	20/10/2021	Registered
NeuroEPO in mild-moderate Alzheimer's disease	20/09/2022	Registered
NeuroEPO in mild-moderate Alzheimer's disease amnesic variant	22/09/2022	Registered
Exploratory, open and multicenter study of the use of the humanized monoclonal antibody itolizumab (antiCD6) in patients with solid tumors.	18/06/2024	Registered
Her1 vaccine in metastatic colon and prostate cancer	16/08/2023	Registered
CIMAvax®-EGF in patients with moderate-severe chronic obstructive pulmonary disease (COPD)	24/03/2025	Registered
CIMAvaxEGF in Non Small Cell Lung Cancer. Exploratory Study of Biomarkers	20/06/2024	Registered
Nimotuzumab in Esophagus premalignant lesions	21/06/2024	Registered
Efficacy and safety of the monoclonal antibody nimotuzumab plus FOLFOX vs. FOLFOX as first-line treatment of patients with unresectable, left-sided, metastatic colorectal cancer. Phase I/II	12/08/2025	Registered
Efficacy and safety of CIMAvax-FOLFOX-BEVA in unresectable, left-sided, metastatic, colorectal cancer. Phase I/II	12/12/2025	Registered
Anti-PD1 2C12 in adult patients with advanced non-small cell lung cancer and unresectable or metastatic melanoma. Phase I-II	17/11/2025	Registered
Anti-PD1 2C12 in patients with relapsed or refractory Hodgkin lymphoma	18/05/2026	Registered
Evaluation of patients with a clinical diagnosis of the amnesic variant of Alzheimer´s disease phenotype without specific treatment.	21/05/2026	Registered
CIMAvax-EGF vaccine Predictor Phase IV	14/12/2015	Registered outdated
Treatment of SARS CoV-2 pneumonia with the anti-CD6 monoclonal antibody itolizumab	12/05/2020	Registered outdated
NGcGM3/VSSP in small cell lung cancer	07/12/2016	Registered outdated
RituxCIM in relapsed or refractory indolent B-cell non-Hodgkin lymphoma	05/11/2013	Registered outdated

Registered Trials

Registration process

CENTER OF MOLECULAR IMMUNOLOGY

About the RPCEC

Useful resources